Metagenomi

11月12日，生物制药公司Ovid Therapeutics$Ovid Therapeutics(OVID)$ 和Metagenomi$Metagenomi(MGX)$ 相继公布领导层变动，引发行业关注。Ovid Therapeutics在投资者关系公告中透露，现任总裁兼首席运营官Meg Alexander将于2026年1月1日起正式接任首席执行官一职。公司联合创始人兼现任CEO Jeremy ...

基因编辑初创公司Metagenomi已采用AWS的Inferentia 2加速器来加速发现拯救生命的潜在疗法，该公司表示其成本比使用英伟达GPU降低了56%。
Metagenomi成立于2018年，正在使用由Jennifer Doudna和Emmanuelle Charpentier开发的诺贝尔奖获奖方法CRISPR，该技术允许对基因序列进行精准编辑。
&#...

$Metagenomi(MGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-304212  Size: 10 KB 网页链接

$Metagenomi(MGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-310971  Size: 4 KB 网页链接

$Metagenomi(MGX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001193125-25-276150  Act: 34  Size: 11 MB 网页链接

$Metagenomi(MGX)$ 8-K Current report, items 1.01 and 1.02 Accession Number: 0001193125-25-226878  Act: 34  Size: 156 KB 网页链接

$Metagenomi(MGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-304221  Size: 4 KB 网页链接

$Metagenomi(MGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-304218  Size: 6 KB 网页链接

$Metagenomi(MGX)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001193125-25-276135  Act: 34  Size: 9 MB 网页链接

$Metagenomi(MGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-310958  Size: 4 KB 网页链接

$Metagenomi(MGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-304177  Size: 6 KB 网页链接

$Metagenomi(MGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-310953  Size: 4 KB 网页链接

$Metagenomi(MGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-310937  Size: 4 KB 网页链接